Alison C Roxby1, Leïla Ben-Youssef2,3, Grace Marx4, Freda Kinoti5, Rose Bosire5, Brandon Guthrie1,6, Romel Mackelprang6, James Kiarie7,8, Grace John-Stewart1,6,9,10, Carey Farquhar1,6,10. 1. Assistant Professor, Departments of Medicine and Global Health, University of Washington, WA, USA. 2. Resident Physician, Department of Emergency Medicine, Alameda County Medical Center, Highland Hospital, Oakland, CA, USA, and University of Washington School of Medicine, WA, USA. 3. Infectious Disease Fellow, Department of Medicine, University of Colorado, Aurora, CO, USA. 4. Physician, Kenya Medical Research Institute, Nairobi, Kenya. 5. Senior Clinical Research Scientist, Kenya Medical Research Institute, Nairobi, Kenya. 6. Assistant Professor, Departments of Epidemiology and Global Health, University of Washington, Seattle WA, USA. 7. Acting Instructor, Department of Global Health, University of Washington, Seattle, WA, USA. 8. Professor, Department of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya and Department of Obstetrics and Gynaecology, Kenyatta National Hospital, Nairobi, Kenya. 9. Professor, Departments of Medicine, Global Health, Pediatrics, and Epidemiology, University of Washington, Seattle, WA, USA. 10. Professor, Departments of Medicine, Epidemiology, Global Health, University of Washington, Seattle, WA, USA.
Abstract
BACKGROUND: World Health Organization (WHO) guidelines recommend dual contraceptive method use with condoms and another contraceptive to reduce both incidence of HIV/sexually transmitted infection transmission and unintended pregnancies. This qualitative study assessed the barriers to and motivations for dual contraceptive use in Kenyan HIV-serodiscordant couples. METHODS: HIV-serodiscordant couples in Nairobi, Kenya, were recruited from two longitudinal cohorts. Qualitative semistructured interviews were conducted using a semistructured questionnaire. Twelve male and 12 female members of serodiscordant couples and 10 women with incident pregnancies during the cohort studies were included. RESULTS: Few couples reported using dual contraceptive methods, with men reporting more condom use than women. No HIV-seropositive men or HIV-seronegative women reported using non-condom contraception. Men and women agreed that men play a dominant role in decisions to use both condoms and contraception in HIV-serodiscordant couples. Participants reported that perceptions of side effects, male partner preference, and reproductive desire were critical factors in contraceptive decisions. Both men and women saw dual contraceptive method use as redundant and a sign of possible unfaithfulness. Many participants actively desired pregnancy, but few were able to accurately define monthly fertility windows. CONCLUSIONS: Dual contraceptive method use was low in these HIV-serodiscordant couples, with some couples finding it unnecessary while using condoms, and others being more focused on conceiving a child. Biomedical HIV prevention, including male circumcision, pre-exposure prophylaxis or antiretroviral therapy to reduce HIV transmission, may be more acceptable strategies to promote safer sexual relations among HIV-serodiscordant couples and safer conception when desired. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
BACKGROUND: World Health Organization (WHO) guidelines recommend dual contraceptive method use with condoms and another contraceptive to reduce both incidence of HIV/sexually transmitted infection transmission and unintended pregnancies. This qualitative study assessed the barriers to and motivations for dual contraceptive use in Kenyan HIV-serodiscordant couples. METHODS: HIV-serodiscordant couples in Nairobi, Kenya, were recruited from two longitudinal cohorts. Qualitative semistructured interviews were conducted using a semistructured questionnaire. Twelve male and 12 female members of serodiscordant couples and 10 women with incident pregnancies during the cohort studies were included. RESULTS: Few couples reported using dual contraceptive methods, with men reporting more condom use than women. No HIV-seropositive men or HIV-seronegative women reported using non-condom contraception. Men and women agreed that men play a dominant role in decisions to use both condoms and contraception in HIV-serodiscordant couples. Participants reported that perceptions of side effects, male partner preference, and reproductive desire were critical factors in contraceptive decisions. Both men and women saw dual contraceptive method use as redundant and a sign of possible unfaithfulness. Many participants actively desired pregnancy, but few were able to accurately define monthly fertility windows. CONCLUSIONS: Dual contraceptive method use was low in these HIV-serodiscordant couples, with some couples finding it unnecessary while using condoms, and others being more focused on conceiving a child. Biomedical HIV prevention, including male circumcision, pre-exposure prophylaxis or antiretroviral therapy to reduce HIV transmission, may be more acceptable strategies to promote safer sexual relations among HIV-serodiscordant couples and safer conception when desired. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Susan Allen; Jareen Meinzen-Derr; Michele Kautzman; Isaac Zulu; Stanley Trask; Ulgen Fideli; Rosemary Musonda; Francis Kasolo; Feng Gao; Alan Haworth Journal: AIDS Date: 2003-03-28 Impact factor: 4.177
Authors: Brandon L Guthrie; Robert Y Choi; Rose Bosire; James N Kiarie; Romel D Mackelprang; Anne Gatuguta; Grace C John-Stewart; Carey Farquhar Journal: AIDS Behav Date: 2010-10
Authors: Robert C Bailey; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; John N Krieger; Carolyn F M Williams; Richard T Campbell; Jeckoniah O Ndinya-Achola Journal: Lancet Date: 2007-02-24 Impact factor: 79.321
Authors: Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum Journal: N Engl J Med Date: 2012-07-11 Impact factor: 91.245
Authors: Nelly R Mugo; Ting Hong; Connie Celum; Deborah Donnell; Elizabeth A Bukusi; Grace John-Stewart; Jonathan Wangisi; Edwin Were; Renee Heffron; Lynn T Matthews; Susan Morrison; Kenneth Ngure; Jared M Baeten Journal: JAMA Date: 2014 Jul 23-30 Impact factor: 56.272
Authors: Tamaryn L Crankshaw; Lynn T Matthews; Janet Giddy; Angela Kaida; Norma C Ware; Jennifer A Smit; David R Bangsberg Journal: Reprod Health Matters Date: 2012-12
Authors: Katrina F Ortblad; Randy M Stalter; Elizabeth A Bukusi; Kenneth Ngure; Andrew Mujugura; Connie Celum; Jared M Baeten; Renee Heffron Journal: AIDS Behav Date: 2020-05
Authors: Blessings Gausi; Maganizo B Chagomerana; Jennifer H Tang; Mina C Hosseinipour; Lisa B Haddad; Tweya Hannock; Sam Phiri Journal: Sex Transm Dis Date: 2018-11 Impact factor: 2.830